Albany, NY -- (SBWIRE) -- 02/23/2016 -- Transparency Market Research holds a major resource pool of market intelligence reports in the global pharmaceutical industry. One of the reports in this database is the report titled "Cancer Hormone Therapy Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 – 2023." This report provides its users with key details necessary to derive an accurate market forecast for a fruitful strategic venture into the global market for cancer hormone therapy.

The key driver of the global cancer hormone therapy market is the increasing prevalence of cancer. Multiple reasons are accountable for this rise in the number of cancer patients across the globe, including the changes in lifestyle, the increasing use of carcinogens, the rise in the number of cigarette smokers, the increase in awareness about the benefits of early diagnosis of cancer, and the growing geriatric population.

The increase in awareness about cancer and its diagnosis applies to both physicians as well as patients. This increase has created a higher scope for growth of alternative therapy procedures for cancer, including hormone therapy, immunotherapy, and target therapy.

Brochure Download: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=7475

One of the key restraints affecting the global cancer hormone therapy market is the list of side-effects associated with it. This list includes vaginal dryness, irregular periods, male impotence, loss of appetite, enlargement of breasts among males, persistent skin rashes, and vaginal spotting.

Hormone therapy is considered to be a key aspect of modern medicine for cancer therapy. It involves modifying the endocrine system in order to administer steroids or inhibitor drugs. The process is done through exogenous administration and can be used to block the activities of specific hormones.

Surgical intervention is also a part of the global cancer hormone therapy market. This involves the removal of specific endocrine organs. One such procedure is oophorectomy, which is the surgical removal of ovaries in the case of ovarian cancer.

Most procedures in the global cancer hormone therapy market are performed in succession to a hormone receptor test, which allows a physician to estimate the quantity of hormones required to make the procedure a success.

According to the World Health Organization, the various types of cancer are collectively responsible for the largest percentage of global morbidity and mortality rates. Nearly 8.2 mn patients lost their lives to cancer in 2012, a year when 14 mn new cases were registered. Over the next two decades, this number is expected to increase by 70%. The WHO also cites five risks involved in human behavior and diet: use of alcohol, use of tobacco, sedentary lifestyles, high BMI, and low consumption of fruits and vegetables.

The key players in the global cancer hormone therapy market are Pfizer, Inc., QuatRx Pharmaceuticals, Merck & Co., Novartis International AG, and AstraZeneca PLC.

Contact us:
Mr. Sudip S
Transparency Market Research
90 State Street,
Suite 700,
Albany
NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/